{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:46:46Z","timestamp":1782776806208,"version":"3.54.5"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000082","name":"Cystic Fibrosis Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Cystic Fibrosis (CF) is a hereditary pulmonary and extra-pulmonary disease that occurs equally in men and women. However, a difference in morbidity and mortality rates between the sexes has been long documented. Similarly, a sex-disparity in disease severity has been reported in asthma as well. Studies done to date point to estrogen as a possible cause of this sex disparity in pulmonary outcomes in both conditions.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>Here, we describe a case of a patient with CF and asthma\/allergic bronchopulmonary aspergillosis (ABPA) undergoing sex reassignment therapy (male-to-female) and the negative impact it had on her lung function and frequency of pulmonary exacerbations in the context of increasing doses of exogenous estrogen.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This case raises the possibility of a link between estrogen and worsening pulmonary outcomes and the need for further studies into transgender individuals with CF and\/or asthma\/ABPA as well as those undergoing high dose estrogen therapy for other indications.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12890-020-01272-x","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T18:02:37Z","timestamp":1598896957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Worsening pulmonary outcomes during sex reassignment therapy in a transgender female with cystic fibrosis (CF) and asthma\/allergic bronchopulmonary aspergillosis: a case report"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7366-193X","authenticated-orcid":false,"given":"G. Y.","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. S.","family":"Quon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,31]]},"reference":[{"key":"1272_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ppul.22967","volume":"49","author":"NB Sweezey","year":"2014","unstructured":"Sweezey NB, Ratjen F. The cystic fibrosis gender gap: potential roles of estrogen. Pediatr Pulmonol. 2014;49:309\u201317. https:\/\/doi.org\/10.1002\/ppul.22967.","journal-title":"Pediatr Pulmonol"},{"key":"1272_CR2","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/resp.12702","volume":"21","author":"D Raghavan","year":"2016","unstructured":"Raghavan D, Jain R. Increasing awareness of sex differences in airway diseases. Respirology. 2016;21:449\u201359. https:\/\/doi.org\/10.1111\/resp.12702.","journal-title":"Respirology"},{"key":"1272_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/ACI.0b013e32835a6dd6","volume":"13","author":"RS Bonds","year":"2013","unstructured":"Bonds RS, Midoro-Horiuti T. Estrogen effects in allergy and asthma. Curr Opin Allergy Clin Immunol. 2013;13:92\u20139. https:\/\/doi.org\/10.1097\/ACI.0b013e32835a6dd6.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"1272_CR4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1136\/thx.2009.116079","volume":"65","author":"I Romieu","year":"2010","unstructured":"Romieu I, Fabre A, Fournier A, Kauffmann F, Varraso R, Mesrine S, Leynaert B, Clavel-Chapelon F. Postmenopausal hormone therapy and asthma onset in the E3N cohort. Thorax. 2010;65:292\u20137. https:\/\/doi.org\/10.1136\/thx.2009.116079.","journal-title":"Thorax"},{"key":"1272_CR5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/ebm1135","volume":"15","author":"J Dratva","year":"2010","unstructured":"Dratva J. Use of oestrogen only hormone replacement therapy associated with increased risk of asthma onset in postmenopausal women. Evid Based Med. 2010;15:190\u20131. https:\/\/doi.org\/10.1136\/ebm1135.","journal-title":"Evid Based Med"},{"key":"1272_CR6","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1001\/archinte.161.22.2717","volume":"161","author":"MJ Hepburn","year":"2024","unstructured":"Hepburn MJ, Dooley DP, Morris MJ. The effects of estrogen replacement therapy on airway function in postmenopausal, asthmatic women. Arch Intern Med. 2024;161:2717\u201320 PMID: DOI:ioi00967.","journal-title":"Arch Intern Med"},{"key":"1272_CR7","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S1081-1206(10)61794-2","volume":"90","author":"CL Haggerty","year":"2003","unstructured":"Haggerty CL, Ness RB, Kelsey S, Waterer GW. The impact of estrogen and progesterone on asthma. Ann Allergy Asthma Immunol. 2003;90:284\u20133 347 [PMID: DOI:S1081\u20131206(10)61794\u20132].","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1272_CR8","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1056\/NEJMoa1106126","volume":"366","author":"SH Chotirmall","year":"2012","unstructured":"Chotirmall SH, Smith SG, Gunaratnam C, Cosgrove S, Dimitrov BD, O'Neill SJ, Harvey BJ, Greene CM, McElvaney NG. Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis. N Engl J Med. 2012;366:1978\u201386. https:\/\/doi.org\/10.1056\/NEJMoa1106126.","journal-title":"N Engl J Med"},{"key":"1272_CR9","volume-title":"How many Adults Identify as Transgender in the United States?","author":"AR Flores","year":"2016","unstructured":"Flores AR, Herman JL, Gates GJ, Brown TNT. How many Adults Identify as Transgender in the United States? The Williams Institute: UCLA School of Law; 2016."}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-020-01272-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-020-01272-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-020-01272-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T23:07:08Z","timestamp":1630364828000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-020-01272-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,31]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1272"],"URL":"https:\/\/doi.org\/10.1186\/s12890-020-01272-x","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,31]]},"assertion":[{"value":"15 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed and signed consent was provided by the patient for this publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"G. Y. L., P. W.\u00a0and J. G. report no conflicts of interest. B. S. Q reports personal fees from Vertex Pharmaceuticals and personal fees from Proteostasis Therapeutics, and grants from CF Canada, CF Foundation, Gilead Sciences and BC Lung Association.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"234"}}